编辑推荐——合并症、药物与性别对慢性肢体威胁性缺血血运重建后截肢率的影响
基于瑞典全国登记数据的观察性队列研究纳入5年内因慢性肢体威胁性缺血接受血运重建的10,617例患者,中位随访2.7年。男性、肾功能不全、糖尿病和心力衰竭独立关联截肢率升高,而他汀类和低剂量乙酰水杨酸使用与截肢率降低相关。肾功能不全是截肢及截肢/死亡的最强独立危险因素。
要点
- 男性、肾功能不全、糖尿病和心力衰竭独立关联血运重建后截肢率升高。
- 他汀类和低剂量乙酰水杨酸使用与截肢率及截肢/死亡风险降低相关。
- 肾功能不全是截肢和截肢/死亡的最强独立危险因素,其次为糖尿病和心力衰竭。
核心结论
- 肾功能不全是血运重建后慢性肢体威胁性缺血患者截肢及截肢/死亡的最强独立危险因素,其次为糖尿病和心力衰竭。
- 男性慢性肢体威胁性缺血患者结局劣于女性。
- 他汀类和低剂量乙酰水杨酸使用与肢体结局改善相关,作者认为这强调预防性用药对降低总体心血管风险和增加保肢的重要性。
研究设计与样本
- 基于人群的观察性队列研究,纳入瑞典5年期间因慢性肢体威胁性缺血接受血运重建的全部个体,共10,617例患者。
- 数据取自并合并自强制性全国医疗登记库,截肢具体情况经个体病历验证。
主要发现
- 血运重建时平均年龄76.8岁,中位随访2.7年(范围0-6.6年)。
- 截肢率升高的独立关联因素:男性(HR 1.20,95%CI 1.09-1.33)、肾功能不全(HR 1.57,95%CI 1.32-1.87)、糖尿病(HR 1.45,95%CI 1.32-1.60)、心力衰竭(HR 1.17,95%CI 1.05-1.31)。
- 截肢率降低的关联因素:他汀类使用(HR 0.71,95%CI 0.64-0.78)、低剂量乙酰水杨酸使用(HR 0.77,95%CI 0.70-0.86)。
- 截肢或死亡复合终点率升高:男性(HR 1.25,95%CI 1.18-1.32)、肾功能不全(HR 1.94,95%CI 1.75-2.14)、心力衰竭(HR 1.50,95%CI 1.40-1.60)、糖尿病(HR 1.31,95%CI 1.23-1.38)。
- 截肢或死亡复合终点风险降低:他汀类使用(HR 0.74,95%CI 0.67-0.82)、低剂量乙酰水杨酸使用(HR 0.82,95%CI 0.77-0.88)。
临床怎么用
- 作者认为这些结果可能有助于指导血运重建手术的患者选择。
- 作者认为他汀类和低剂量乙酰水杨酸与肢体结局改善相关,强调预防性用药对降低总体心血管风险和增加保肢的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: Chronic limb threatening ischaemia (CLTI) has a high risk of amputation and mortality. Increased knowledge on how sex, comorbidities, and medication influence these outcomes after revascularisation may help optimise results and patient selection. METHODS: This population based observational cohort study included all individuals revascularised for CLTI in Sweden during a five year period (10,617 patients in total). Data were retrieved and merged from mandatory national healthcare registries, and specifics on amputations were validated with individual medical records. RESULTS: Mean age at revascularisation was 76.8 years. Median follow up was 2.7 years (range 0-6.6 years). Male sex (hazard ratio [HR] 1.20, 95% confidence interval [CI] 1.09-1.33), renal insufficiency (HR 1.57, 95% CI 1.32-1.87), diabetes (HR 1.45, 95% CI 1.32-1.60), and heart failure (HR 1.17, 95% CI 1.05-1.31) were independently associated with an increased amputation rate, whereas the use of statins (HR 0.71, 95% CI 0.64-0.78) and low dose acetylsalicylic acid (HR 0.77, 95% CI 0.70-0.86) were associated with a reduced amputation rate. For the combined end point of amputation or death, an association with increased rates was found for male sex (HR 1.25, 95% CI 1.18-1.32), renal insufficiency (HR 1.94, 95% CI 1.75-2.14), heart failure (HR 1.50, 95% CI 1.40-1.60), and diabetes (HR 1.31, 95% CI 1.23-1.38). The use of statins (HR 0.74, 95% CI 0.67-0.82) and low dose acetylsalicylic acid (HR 0.82, 95% CI 0.77-0.88]) were related to a reduced risk of amputation or death. CONCLUSIONS: Renal insufficiency is the strongest independent risk factor for both amputation and amputation/death in revascularised CLTI patients, followed by diabetes and heart failure. Men with CLTI have worse outcomes than women. These results may help govern patient selection for revascularisation procedures. Statin and low dose acetylsalicylic acid are associated with an improved limb outcome. This underlines the importance of preventive medication to reduce general cardiovascular risk and increase limb salvage.
引用
- Baubeta Fridh E, Andersson M, Thuresson M, et al. Editor's Choice - Impact of Comorbidity, Medication, and Gender on Amputation Rate Following Revascularisation for Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2018. PMID: 30093176. doi:10.1016/j.ejvs.2018.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。